Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.

被引：0
|
作者：
Sehn, Laurie Helen
Chamuleau, Martine
Lenz, Georg
Clausen, Michael
Haioun, Corinne
Izutsu, Koji
Davies, Andrew John John
Zhu, Jun
Oki, Toshiko
Szafer-Glusman, Edith
Conlon, Rebekah
Chiou, Hueiyu
Ipe, David
Elliott, Brian
Wu, Jun
Salles, Gilles A.
机构：
[1] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Vrije Univ, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[4] Univ Hosp Munster, Munster, Germany
[5] Vejle Hosp, Vejle, Denmark
[6] Hop Henri Mondor, Creteil, France
[7] Natl Canc Ctr, Tokyo, Japan
[8] Univ Southampton, Southampton NIHR Canc Res UK Expt Canc Med, Southampton, Hants, England
[9] Beijing Canc Hosp, Beijing, Peoples R China
[10] AbbVie Inc, N Chicago, IL USA
[11] Genmab, Plainsboro, NJ USA
[12] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7592
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [2] Phase I Trial of Carfilzomib plus R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Dean, Robert M.
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Pohlman, Brad
    Winter, Allison M.
    Krauspe, Ethan
    Collier, Patrick
    D'Andrea, Christopher
    Morrison, Ashley
    Lehmann, Sarah
    Tomlinson, Benjamin K.
    Cooper, Brenda
    de Lima, Marcos
    Ondrejka, Sarah L.
    Hsi, Eric D.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [3] Safety Results of a Phase I Study of Zandelisib plus R-CHOP in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL)
    Jagadeesh, Deepa
    Caimi, Paolo
    Winter, Allison
    Wei, Wei
    Pohlman, Brad
    D'Andrea, Christopher
    Rhoades, Emily
    Dean, Robert M.
    Hill, Brian T.
    BLOOD, 2023, 142
  • [4] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] R-CHOP compared to R-CHOP plus X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis
    Pasvolsky, Oren
    Rozental, Alon
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    ACTA ONCOLOGICA, 2021, 60 (06) : 744 - 749
  • [6] R-CHOP vs. R-CHOP plus X for Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
    Pasvolsky, Oren
    Rozental, Alon
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S243 - S243
  • [7] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [8] R-CHOP Vs. R-CHOP plus X for Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
    Pasvolsky, Oren
    Rozental, Alon
    Raanani, Pia
    Gafter-Gvili, Anat
    Gurion, Ronit
    BLOOD, 2019, 134
  • [9] First-Line Treatment With Subcutaneous Epcoritamab plus R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
    Falchi, Lorenzo
    Offner, Fritz
    Belada, David
    Brody, Joshua
    Linton, Kim M.
    Karimi, Yasmin
    Cordoba, Raul
    Snauwaert, Sylvia
    Abbas, Aqeel
    Wang, Liwei
    Wu, Jun
    Elliott, Brian
    Clausen, Michael Roost
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S380 - S380
  • [10] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Proctor, B. R.
    Hui, D.
    Donaldson, J.
    Savage, K. J.
    Shenkier, T. N.
    Hoskins, P. J.
    Klasa, R.
    Randy, G.
    Joseph, C.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345